SKIN earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Hold, P/E -13.60. Updated 2026-07-23.
SkinHealth Systems (SKIN) Research Hub
SkinHealth Systems (SKIN) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 0.7 USD (+1.45%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -13.60, market cap 0.10B. This hub links to the full technical, earnings and options research available for SKIN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7 USD (+1.45%) |
| 52-week range | 0.59 USD – 1.18 USD |
| Trend regime | Range |
| 14-day RSI | 54.9 (Neutral) |
| Trailing P/E | -13.60 |
| Market cap | 0.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for SKIN
Covered Call on SKIN: how it works, illustrative setup around the real 0.7 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SKIN: how it works, illustrative setup around the real 0.7 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SKIN: how it works, illustrative setup around the real 0.7 USD price, max profit/loss, breakeven and when to use it. Educational.
SKIN technical analysis: range, last 0.7 USD, RSI 54.9, 52w range 0.59 USD–1.18 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SKIN in?
SkinHealth Systems (SKIN) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is SKIN in an uptrend or downtrend?
As of 2026-09-11, SKIN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SKIN's trailing P/E ratio?
SKIN's trailing P/E is -13.60, with a market cap of 0.10B. See the earnings research page for full valuation detail.
When does SKIN next report earnings?
SKIN is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.04 USD.